Basic info
Industry
biotechnology research
Sectors
Biotechnology
Non-Small Cell Lung Cancer
Artificial Intelligence
Biopharma Services
lung disease
biomarkers
Proteomics
oncology
liquid biopsy
Genomic Testing
Lung Nodules
Companion Diagnostics
Prognostic and Mutation Tests
Health Diagnostics
cancer diagnostics
Health Care
Predictive
Clinical Trials
Mass Spectrometry Analysis of Biological Samples
Molecular Diagnostics
Nodule Management
ddPCR
Medical
lung cancer
Date founded
2005
Funding rounds raised
Total raised
$50M
from 2 investors over 2 rounds
B
Biodesix, Inc. raised $50M on November 16, 2022
Investors: Perceptive Advisors
B
Biodesix, Inc. raised $50M on March 7, 2022
Investors: Lincoln Park Capital, LLC